Clinical trial
6 Months of Bedaquiline, Delamanid, Linezolid and Levoffoxacin in RR-TB Patients in Hubei Province
NCT07198685 is registered in ClinicalTrials.gov with Wuhan Pulmonary Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 6 Months of Bedaquiline, Delamanid, Linezolid and Levoffoxacin in RR-TB Patients in Hubei Province
- Lead sponsor
- Wuhan Pulmonary Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 30, 2025
- Completion date
- September 30, 2028
- Enrollment
- 52 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
treat to target, treatment duration